Abstract
CRMP2, also known as DPYSL2/DRP2, Unc-33, Ulip or TUC2, is a cytosolic phosphoprotein that mediates axon/dendrite specification and axonal growth. Mapping the CRMP2 interactome has revealed previously unappreciated functions subserved by this protein. Together with its canonical roles in neurite growth and retraction and kinesin-dependent axonal transport, it is now known that CRMP2 interacts with numerous binding partners to affect microtubule dynamics; protein endocytosis and vesicular cycling, synaptic assembly, calcium channel regulation and neurotransmitter release. CRMP2 signaling is regulated by post-translational modifications, including glycosylation, oxidation, proteolysis and phosphorylation; the latter being a fulcrum of CRMP2 functions. Here, the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders are discussed and evidence is presented for therapeutic strategies targeting CRMP2 functions.
Original language | English (US) |
---|---|
Pages (from-to) | 749-771 |
Number of pages | 23 |
Journal | Future Neurology |
Volume | 7 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2012 |
Keywords
- Alzheimers disease
- CRMP2
- CRMP2 hyperphosphorylation
- CRMP2/CLN6/KLC4 signaling complex
- amyotrophic lateral sclerosis
- axon elongation
- excitotoxicity
- multiple sclerosis
- neuropathic pain
- oxidative damage
ASJC Scopus subject areas
- Neurology
- Clinical Neurology